BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 15919754)

  • 21. Histone deacetylase inhibitors restore radioiodide uptake and retention in poorly differentiated and anaplastic thyroid cancer cells by expression of the sodium/iodide symporter thyroperoxidase and thyroglobulin.
    Furuya F; Shimura H; Suzuki H; Taki K; Ohta K; Haraguchi K; Onaya T; Endo T; Kobayashi T
    Endocrinology; 2004 Jun; 145(6):2865-75. PubMed ID: 14976143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcription factor Nkx-2.5 induces sodium/iodide symporter gene expression and participates in retinoic acid- and lactation-induced transcription in mammary cells.
    Dentice M; Luongo C; Elefante A; Romino R; Ambrosio R; Vitale M; Rossi G; Fenzi G; Salvatore D
    Mol Cell Biol; 2004 Sep; 24(18):7863-77. PubMed ID: 15340050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low concentrations of the histone deacetylase inhibitor, depsipeptide (FR901228), increase expression of the Na(+)/I(-) symporter and iodine accumulation in poorly differentiated thyroid carcinoma cells.
    Kitazono M; Robey R; Zhan Z; Sarlis NJ; Skarulis MC; Aikou T; Bates S; Fojo T
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3430-5. PubMed ID: 11443220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
    Law AY; Lai KP; Lui WC; Wan HT; Wong CK
    Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histone deacetylase inhibition affects sodium iodide symporter expression and induces 131I cytotoxicity in anaplastic thyroid cancer cells.
    Pugliese M; Fortunati N; Germano A; Asioli S; Marano F; Palestini N; Frairia R; Boccuzzi G; Catalano MG
    Thyroid; 2013 Jul; 23(7):838-46. PubMed ID: 23531031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
    Zhao S; Venkatasubbarao K; Li S; Freeman JW
    Cancer Res; 2003 May; 63(10):2624-30. PubMed ID: 12750289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.
    Cengic N; Baker CH; Schütz M; Göke B; Morris JC; Spitzweg C
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4457-64. PubMed ID: 15941870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histone acetylation influences thyroid hormone and retinoic acid-mediated gene expression.
    Garcia-Villalba P; Jimenez-Lara AM; Castillo AI; Aranda A
    DNA Cell Biol; 1997 Apr; 16(4):421-31. PubMed ID: 9150429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple histone deacetylases repress tumor suppressor gene ARHI in breast cancer.
    Feng W; Lu Z; Luo RZ; Zhang X; Seto E; Liao WS; Yu Y
    Int J Cancer; 2007 Apr; 120(8):1664-8. PubMed ID: 17230502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promoter specific sensitivity to inhibition of histone deacetylases: implications for hormonal gene control, cellular differentiation and cancer.
    Dressel U; Renkawitz R; Baniahmad A
    Anticancer Res; 2000; 20(2A):1017-22. PubMed ID: 10810390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines].
    Chen YX; Fang JY; Lu J; Qiu DK
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):312-7. PubMed ID: 15059516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acetylation of histones associated with the p21WAF1/CIP1 gene by butyrate is not sufficient for p21WAF1/CIP1 gene transcription in human colorectal adenocarcinoma cells.
    Kobayashi H; Tan EM; Fleming SE
    Int J Cancer; 2004 Mar; 109(2):207-13. PubMed ID: 14750171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells.
    Schmutzler C; Winzer R; Meissner-Weigl J; Köhrle J
    Biochem Biophys Res Commun; 1997 Nov; 240(3):832-8. PubMed ID: 9398654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cotransfected sodium iodide symporter and human tyroperoxidase genes following human telomerase reverse transcriptase promoter for targeted radioiodine therapy of malignant glioma cells.
    Li W; Tan J; Wang P; Wu P
    Cancer Biother Radiopharm; 2011 Aug; 26(4):443-51. PubMed ID: 21797672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In thyroid cancer cell lines expression of periostin gene is controlled by p73 and is not related to epigenetic marks of active transcription.
    Puppin C; Passon N; Frasca F; Vigneri R; Tomay F; Tomaciello S; Damante G
    Cell Oncol (Dordr); 2011 Apr; 34(2):131-40. PubMed ID: 21290209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y; Fatima N; Dufau ML
    Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of human sodium iodide symporter gene therapy for breast cancer by HDAC inhibitor mediated transcriptional modulation.
    Kelkar MG; Senthilkumar K; Jadhav S; Gupta S; Ahn BC; De A
    Sci Rep; 2016 Jan; 6():19341. PubMed ID: 26777440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The comparative effects of gene modulators on thyroid-specific genes and radioiodine uptake.
    Tuncel M; Aydin D; Yaman E; Tazebay UH; Güç D; Doğan AL; Taşbasan B; Uğur O
    Cancer Biother Radiopharm; 2007 Jun; 22(3):443-9. PubMed ID: 17679169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HDAC inhibitors TSA and sodium butyrate enhanced the human IL-5 expression by altering histone acetylation status at its promoter region.
    Han S; Lu J; Zhang Y; Cheng C; Li L; Han L; Huang B
    Immunol Lett; 2007 Feb; 108(2):143-50. PubMed ID: 17270283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Doxorubicin enhances the expression of transgene under control of the CMV promoter in anaplastic thyroid carcinoma cells.
    Kim KI; Kang JH; Chung JK; Lee YJ; Jeong JM; Lee DS; Lee MC
    J Nucl Med; 2007 Sep; 48(9):1553-61. PubMed ID: 17704247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.